Fertility and Sterility
Volume 84, Issue 6 , Pages 1628-1636, December 2005

Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts

Presented in part at the 21st Annual Meeting of the Fertility Society of Australia, Gold Coast, Queensland, Australia, October 23–26, 2002.

Sydney IVF, Sydney, New South Wales, Australia

Received 15 December 2004; received in revised form 24 May 2005; accepted 24 May 2005.

Objective

To compare multiple-cell trophectoderm biopsy for preimplantation genetic diagnosis (PGD) from day-5 blastocysts with previously published experience with day-3 cleavage-stage embryos.

Design

Retrospective review of laboratory and clinical experience.

Setting

Sydney IVF, a private clinic in Australia.

Patient(s)

Preimplantation genetic diagnosis (PGD) patients age < 44 years with at least one IVF blastocyst suitable for biopsy, recruited from January 2002 through August 2004.

Intervention(s)

Biopsy of trophectoderm from blastocysts on day 5 or 6, with same-day PGD for mutation testing, translocation testing, aneuploidy screening or sex selection. Spare, normal biopsied blastocysts were cryostored for possible later transfer.

Main Outcome Measure(s)

Fetal heart–positive pregnancy rate and accumulating live birth rate after adding results from biopsied fresh and frozen blastocysts for particular couples.

Result(s)

In 231 started PGD treatment cycles, unambiguous results were obtained from 974 of 1,050 biopsied blastocysts (93%); all blastocysts survived the biopsy procedure by reconstitution of their blastocele. One hundred nineteen women (median age, 36 years) have had 127 blastocysts transferred fresh (fetal heart–positive implantation rate, 41%). Of 146 blastocysts cryostored, 27 have been thawed (all with >50% cell survival) and 24 transferred (implantation rate, 26%). To date, 53 pregnancies have been delivered or are ongoing, with an additional 4 clinical miscarriages (7%) and 6 subclinical miscarriages (total miscarriage rate, including biochemical pregnancies, 16%). There were no twin pregnancies.

Conclusion(s)

With technically appropriate blastocyst culture and freezing, blastocyst biopsy and cryostorage and later transfer of biopsied blastocysts is shown to be a practical and probably preferable path to preimplantation genetic testing of embryos compared with cleavage-stage embryo biopsy, being accompanied by a high implantation rate (and hence more conducive to elective single embryo transfer) and by a low rate of twinning and miscarriage.

Key Words:  Blastocyst , cryostorage , elective single embryo transfer , IVF , live births , multiple pregnancy , preimplantation genetic diagnosis (PGD) , pregnancy outcome , twin pregnancy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The Sydney IVF culture medium suite is licensed for manufacture to William A. Cook (Australia) and Cook Ob/Gyn (Spencer, IN) by Sydney IVF Limited. Live birth data at Sydney IVF are verified through random sampling by the auditing firm Ernst and Young, Sydney, Australia.

PII: S0015-0282(05)03035-9

doi:10.1016/j.fertnstert.2005.05.063

Fertility and Sterility
Volume 84, Issue 6 , Pages 1628-1636, December 2005